NK

Navneet Kaur Khanna

Director Director DIN 07805903
DIN 07805903 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Navneet Kaur Khanna

Data last updated:

Navneet Kaur Khanna was a Director at Satguru Distributors Private Limited (2017–2025) and Director at Grj Pharma Private Limited (from 2017). The companies operate in Pharma.

DIN 07805903
Primary Designation Director
Industry Pharma
First Appointment 29 May 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Satguru Distributors Private Limited U74999DL2017PTC318365
Director29 May 20172017₹1.94 Cr (FY 2024)Active
Grj Pharma Private Limited U74999DL2017PTC320306
Director07 Jul 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Grj Pharma Private Limited
Satguru Distributors Private Limited
Premium access

Shareholding and investment profile for Navneet Kaur Khanna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navneet Kaur Khanna

Navneet Kaur Khanna was first appointed on 29 May 2017 as Director at Satguru Distributors Private Limited.

Navneet Kaur Khanna held 2 earlier board appointments: Satguru Distributors Private Limited (Director, 29 May 2017 to 03 Sep 2025); Grj Pharma Private Limited (Director, from 07 Jul 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available